22 Jul ARMI | BioFabUSA
Richard McFarland, Chief Regulatory Officer
Oct. 5 | 9:15am | FLW Ballroom F
Manchester, NH
(Private)
ARMI | BioFabUSA is a national public-private partnership advancing the manufacturing capabilities required to realize the promise of regenerative medicine and advanced therapies. Through a network of nearly 200 organizations spanning industry, academia, government, healthcare, and investment communities, ARMI works to address the manufacturing, workforce, regulatory, and commercialization challenges that limit scale and adoption. As one of the nation’s Manufacturing Innovation Institutes, ARMI develops manufacturing technologies, workforce solutions, and collaborative infrastructure that help translate scientific breakthroughs into scalable, commercially viable products. By bringing together stakeholders across the regenerative medicine value chain, ARMI is helping strengthen domestic biomanufacturing capabilities, accelerate commercialization, and establish the foundation needed to support the next generation of cell, tissue, and regenerative medicine products.